Clinical trial
Genetic Markers in Patients With Colorectal Cancer
NCT00014079 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00014079 |
|---|---|
| Title | Genetic Markers in Patients With Colorectal Cancer |
| Official title | Clinical Significance of Genetic Markers in Colon Cancer |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Colorectal Cancer |
| Intervention type | Genetic |
| Interventions | DNA stability analysis, loss of heterozygosity analysis, microsatellite instability analysis |
| Enrollment | 675 |
| Start date | Sep 1, 1997 |
| Primary completion | Jul 1, 2003 |
| Completion | May 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | Jul 13, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: